Atlas Trials

Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS

Clinical trial NCT03480022 · COMPLETED

Trial details

NCT number
NCT03480022
Sponsor
Woman's
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Pre DiabetesPolycystic Ovary SyndromeObesity Android
Start date
2018-09-26
Primary completion
2021-02-22
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.